Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.50 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3857079 | 0.89 | CA12 (0.47) | CA12CA7CA14CA9CA1 | |
| SCHEMBL28428673 | 0.87 | CA12 (0.46) | CA12CA7CA14CA9CA1 | |
| Potassium Ion SCHEMBL28435351 | 0.85 | CA12 (0.42) | CA12CA7CA14CA9CA1 | |
| Tetrapropylammonium SCHEMBL18575144 | 0.84 | CA12 (0.36) | CA12CA7CA14CA9CA1 | |
| Tetrapentylammonium SCHEMBL18575134 | 0.81 | EPHX1 (0.39) | CA12CA7CA14CA9BBOX1 | |
| Tetrabuthylammonium SCHEMBL18575138 | 0.81 | EPHX1 (0.39) | CA12CA7CA14CA9BBOX1 | |
| Water SCHEMBL28173239 | 0.78 | CA12 (0.39) | CA12CA7CA14CA9CA1 | |
| SCHEMBL18747671 | 0.78 | KDM4E (0.42) | CA12CA7CA14CA9CA1 | |
| SCHEMBL18747649 | 0.78 | KDM4E (0.42) | CA12CA7CA14CA9CA1 | |
| SCHEMBL18747702 | 0.78 | KDM4E (0.42) | CA12CA7CA14CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611104-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-09-03 | — | — | EP | claimed |
| US-20250219149-A1 | NON-AQUEOUS ELECTROLYTE AND SODIUM-ION BATTERY AND ELECTRIC APPARATUS INCLUDING SUCH ELECTROLYTE | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-07-03 | — | — | US | claimed |
| WO-2024152146-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | 宁德时代新能源科技股份有限公司 | 2024-07-25 | — | — | WO | claimed |
| CN-116813509-A | Synthesis method of sodium 2- (cyclohexylamine) ethanesulfonate | 湖南恒飞生物医药股份有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-108264622-B | Waterborne polyurethane, preparation intermediate and preparation method thereof | 比亚迪股份有限公司 | 2020-06-19 | — | — | CN | claimed |
| WO-2025264733-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | PERIMETER SOLUTIONS, LP (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4611104-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-09-03 | — | — | EP | disclosed |
| US-12398099-B2 | Multi-aziridine compound | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-08-26 | — | — | US | disclosed |
| US-20250219149-A1 | NON-AQUEOUS ELECTROLYTE AND SODIUM-ION BATTERY AND ELECTRIC APPARATUS INCLUDING SUCH ELECTROLYTE | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-07-03 | — | — | US | disclosed |
| US-12281072-B2 | Multi-aziridine compound | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-04-22 | — | — | US | disclosed |
| CN-119144369-A | Composite polyurea sulfonate lubricating grease and preparation method thereof | 亚培烯科技(上海)有限公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024213654-A1 | GENTLE METHOD FOR PRODUCING TRANSPARENT BIOLOGICAL PREPARATIONS FOR EXAMINATION BY LIGHT MICROSCOPY | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS (UNIVERSITÄTSMEDIZIN) (DE) | 2024-10-17 | — | — | WO | disclosed |
| WO-2016162784-A1 | FIDUCIAL MARKER FOR USE IN STEREOTACTIC RADIOSURGERY AND PROCESS OF PRODUCTION | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2016-10-13 | — | — | WO | disclosed |
| EP-3017058-A1 | PHOSPHORESCENCE-BASED HYDROGEN PEROXIDE ASSAY FOR THE DETECTION OF HYDROGEN PEROXIDE IN HUMAN SERUM AND WATER SAMPLES | Universität Leipzig (DE) | 2016-05-11 | — | — | EP | disclosed |
| WO-2015000910-A1 | PHOSPHORESCENCE-BASED HYDROGEN PEROXIDE ASSAY FOR THE DETECTION OF HYDROGEN PEROXIDE IN HUMAN SERUM AND WATER SAMPLES | UNIVERSITÄT LEIPZIG (DE) | 2015-01-08 | — | — | WO | disclosed |
| US-20070269843-A1 | Diagnostic Assays That Use Mycobacteriophages | INTEGRATED RESEARCH TECHNOLOGY, LLC. | 2007-11-22 | — | — | US | disclosed |
| WO-2005116243-A2 | IMPROVEMENTS TO DIAGNOSTIC ASSAYS THAT USE MYCOBACTERIOPHAGES | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 2005-12-08 | — | — | WO | disclosed |
| EP-0594297-B1 | Process for preparing fatty acid esters and amides of sulfonic acid salts | RHONE POULENC SURFACTANTS (US) | 1996-05-08 | — | — | EP | disclosed |
| EP-0594297-A1 | Process for preparing fatty acid esters and amides of sulfonic acid salts | RHONE-POULENC SURFACTANTS AND SPECIALTIES, L.P. (US) | 1994-04-27 | — | — | EP | disclosed |
| US-5300665-A | Heating mixture of fatty acid and/or ester and hydroxyalkyl-or aminoalkylsulfonate in presence of promoter in oxygen-free atmosphere while removing water or alcohol formed, distilling, cooling | RHONE-POULENC SURFACTANTS AND SPECIALTIES, L.P. (US) | 1994-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281072-B2 | Multi-aziridine compound | HRH3, QDPR, HRH4 | CA12 1942/4885CA1 2307/4885CA2 2044/4885 |
| US-12398099-B2 | Multi-aziridine compound | HRH3, QDPR, HRH4 | CA12 2407/4885CA1 2633/4885CA2 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.